Brian D. Robertson

This study shows that mycobacterial lipoarabinomannan impairs macrophage ability to kill Aspergillus fumigatus conidia and increases inflammatory cytokine release in vitro.

This study identifies SerC as a critical metabolic enzyme in Mtb, showing its essential role in survival and revealing it as a potential drug target for TB therapy.

This study identifies a hyper-inflammatory immune response in HIV-associated TB meningitis, marked by cytotoxic CD8 T cells, activated neutrophils, and type 1 interferon signaling.

This study shows that Rv3400, a β-phosphoglucomutase in M. tuberculosis, is essential for trehalose metabolism, as its deletion increases β-D-glucose 1-phosphate and causes growth defects on trehalose.

The paper introduces a novel ex-vivo model using precision-cut lung slices in air-liquid interface to study Pulmonary Aspergillosis and assess antifungal treatments.

This paper develops a BCG skin challenge model to assess TB vaccines using non-invasive imaging and shows vaccination reduces fluorescence, indicating immune response.